Back to Search Start Over

Overweight and obesity as predictors of early mortality in Mexican children with acute lymphoblastic leukemia: a multicenter cohort study.

Authors :
Núñez-Enríquez, Juan Carlos
Gil-Hernández, Ana Elena
Jiménez-Hernández, Elva
Fajardo-Gutiérrez, Arturo
Medina-Sansón, Aurora
Flores-Lujano, Janet
Espinoza-Hernández, Laura Eugenia
Duarte-Rodríguez, David Aldebarán
Amador-Sánchez, Raquel
Peñaloza-González, José Gabriel
Torres-Nava, José Refugio
Espinosa-Elizondo, Rosa Martha
Flores-Villegas, Luz Victoria
Merino-Pasaye, Laura Elizabeth
Pérez-Saldivar, María Luisa
Dorantes-Acosta, Elisa María
Cortés-Herrera, Beatriz
Solis-Labastida, Karina Anastacia
Núñez-Villegas, Nora Nancy
Velázquez-Aviña, Martha Margarita
Source :
BMC Cancer; 7/18/2019, Vol. 19 Issue 1, pN.PAG-N.PAG, 1p, 2 Charts, 5 Graphs
Publication Year :
2019

Abstract

<bold>Background: </bold>Mexico City has one of the highest incidences and mortality rates of acute lymphoblastic leukemia (ALL) in the world and a high frequency of early relapses (17%) and early mortality (15%). Otherwise, childhood overweight and obesity are reaching epidemic proportions. They have been associated with poor outcomes in children with ALL. The aim of present study was to identify if overweight and obesity are predictors of early mortality and relapse in Mexican children with ALL.<bold>Methods: </bold>A multicenter cohort study was conducted. ALL children younger than 15 years old were included and followed-up during the first 24 months after diagnosis. Overweight and obesity were classified according World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) criteria. Early mortality and early relapses were the main outcomes.<bold>Results: </bold>A total of 1070 children were analyzed. Overweight/obesity at diagnosis were predictors of early mortality (WHO: HR = 1.4, 95%CI:1.0-2.0; CDC: HR = 1.6, 95%CI:1.1-2.3). However, no associations between overweight (WHO: HR = 1.5, 95%CI:0.9-2.5; CDC: HR = 1.0; 95% CI:0.6-1.6) and obesity (WHO: HR = 1.5, 95%CI:0.7-3.2; CDC: HR = 1.4; 95%CI:0.9-2.3) with early relapse were observed.<bold>Conclusions: </bold>Overweight and obese patients embody a subgroup with high risk of dying during leukemia treatment. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712407
Volume :
19
Issue :
1
Database :
Complementary Index
Journal :
BMC Cancer
Publication Type :
Academic Journal
Accession number :
137587671
Full Text :
https://doi.org/10.1186/s12885-019-5878-8